The Role of Conventional and Right-Sided ECG Screening for Subcutaneous ICD in a Tetralogy of Fallot Population

Autores de IIS La Fe

• Pau Alonso Fernández

  Autor

• Joaquín Osca Asensi

  Autor

• Óscar Cano Pérez

  Autor

• Pedro Pimenta Fermisson-Ramos

  Autor

• Ana Andrés Lahuerta

  Autor

• Jaime Yagüe Mayans

  Autor

• José Millet

  Autor

• Joaquín Rueda Soriano

  Autor

• María José Sancho-Tello De Carranza

  Autor

Grupos

• Grupo de Investigación Clínica y Traslacional en Cardiología

• Regeneración y Trasplante Cardíaco

Abstract

Background: Information regarding suitability for subcutaneous implantable cardioverter-defibrillator (S-ICD) implant in tetralogy of Fallot (ToF) population is scarce and needs to be further explored. The aims of our study were: (1) to determine the proportion of patients with ToF eligible for S-ICD, (2) to identify the optimal sensing vector in ToF patients, (3) to test specifically the eligibility for S-ICD with right-sided screening, and (4) to compare with the proportion of eligible patients in a nonselected ICD population. Methods: We recruited 60 consecutive patients with ToF and 40 consecutive nonselected patients. Conventional electrocardiographic screening was performed as usual. Right-sided alternative screening was studied by positioning the left arm and right arm electrodes 1 cm right lateral to the xiphoid midline. The Boston Scientific electrocardiogram (ECG) screening tool was utilized. Results: We found a higher proportion of patients with right-sided positive screening in comparison with standard screening (77 +/- 0.4% vs. 67 +/- 0.4%; P < 0.0001) and a trend to higher number of appropriate leads in right-sided screening (1.3 +/- 1 vs. 1.1 +/- 1 ms; P = 0.07). Patients who failed the screening had a longer QRS duration and longer QT interval. Standard and right-sided screening showed a higher percent of positive patients in the control group compared to ToF patients (P < 0.001). Conclusion: Right-sided screening was associated with a significant 10% increase in S-ICD eligibility in ToF patients. When comparing with an acquired cardiomyopathies group, ToF showed a lower eligibility for S-ICD. The most appropriate ECG vector was the alternate vector in contrast to what is observed in the general population.

Keywords

• subcutaneous implantable cardioverter-defibrillator; tetralogy of Fallot; ECG screening; right-sided screening